Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;24(1):72-79.
doi: 10.1007/s11655-017-2901-2. Epub 2017 Oct 6.

Review of Anemone raddeana Rhizome and its pharmacological effects

Affiliations
Review

Review of Anemone raddeana Rhizome and its pharmacological effects

Shu-Ling Wang et al. Chin J Integr Med. 2018 Jan.

Abstract

The chemical compositions of Anemone raddeana Rhizome, a kind of traditional Chinese medicine, were reviewed, along with its bioactivity and pharmacological properties and method improvements of extracting and detecting triterpenoid saponins. A. raddeana Rhizome is used to treat neuralgia and rheumatism, and is rich in triterpenoid saponins, most of which are pentacyclic, with oleanane as the nucleus. So far, 37 triterpenoid saponins have been determined from the herb. Its reported bioactivity and pharmacological properties have been described as anticancerous, antimicrobial, anti-inflammatory, analgesic, antipyretic, anticonvulsive, antihistaminic, and sedative. It has also been used for the induction of the humoral immune response and treatment of liver fibrosis in chronic hepatitis. However, the herb also has hemolytic effects and can be toxic, which limits its clinical application. Further studies are needed on the pharmaceutical functions, mechanisms, and immunological responses to contribute to the herb's clinical applications.

Keywords: Anemone raddeana Rhizome; Chinese medicine; analgesic; anti-inflammatory; anticancerous; antimicrobial; pharmacological effect; phytochemical constituent.

PubMed Disclaimer

References

    1. Int Immunopharmacol. 2008 Aug;8(8):1095-102 - PubMed
    1. Clin Chim Acta. 2002 Nov;325(1-2):91-6 - PubMed
    1. Clin Sci (Lond). 1998 May;94(5):461-71 - PubMed
    1. Int J Biol Macromol. 2012 Apr 1;50(3):632-6 - PubMed
    1. Arch Biochem Biophys. 1991 Mar;285(2):325-30 - PubMed

LinkOut - more resources